Clinical Trial Details


Research Study Summary

Clinical trial to test a study drug in Patients with Chronic Hepatitis C


The purpose of this study is to evaluate the safety and effectiveness of an FDA-approved study drug as a sleep aid as compared to placebo (an inactive substance) in the treatment of insomnia associated with interferon-induced insomnia in patients with chronic hepatitis C (CHC). In addition, another purpose of this study is to evaluate whether successful treatment of insomnia decreases the likelihood of developing depression which can occur during interferon treatment.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

  • Be at least 18 through 65 years of age
  • A documented history of chronic hepatitis C
  • Currently receiving interferon treatment in the Gastroenterology Department at Montefiore Medical Center

You will not qualify if you:

  • Are pregnant or breast-feeding
  • A prior history of a suicide attempt in the past 6 months
  • A current history of any of the following sleep disorders- sleep apnea, periodic limb movement disorder, or restless leg syndrome.
  • Any unstable medical illnesses
  • Have participated in another clinical trial within the past 30 days.

Research being conducted by:

To Learn more

CW ID: 118127
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Both Male and Female
18 to 65 Years
Overall Status
Facility Type


Gregory Asnis, MD
Biomedical Research Alliance of New York
Montefiore Medical Center
Anxiety and Depression Clinic
111 East 210th Street
Bronx, NY 10467
Phone: 718-920-4287

View Map

Research Center Information:

Biomedical Research Alliance of New York

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.